Atopic Dermatitis Points of Discussion - Episode 3: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

Identifying Research GapsIn this final episode, the group discusses what research is still needed to better understand the risks and benefits of JAK inhibitors for the treatment of moderate-to-severe atopic dermatitis in children.

Om Podcasten

The Pediatric Dermatology Research Alliance (PeDRA) is vibrant research network pursuing the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.